Alexandra has over 8 years of Business Development, Commercial Operations and Biotherapeutics Research experience.

She has been involved in a range of strategic consulting and transaction advisory projects, including buy- and sell-side mandates covering early- and late-stage projects in various indication areas, including oncology, metabolic disease, immunology, rare diseases, infectious diseases and wound care.

Alexandra holds a BSc of Molecular Biotechnology from the Technical University of Munich and a BSc in International Business from the University of Maastricht.